VERAXA Biotech Announces Regulatory Progress with its BiTACĀ®-TCE Development Plan

Go back to VERAXA Biotech Announces Regulatory Progress with its BiTACĀ®-TCE Development Plan
(NASDAQ: VRXA) Delayed: 1.13 --0 (-0%)
Previous Close $1.13    52 Week High $ 
Open $1.13    52 Week Low $ 
Day High $1.16    P/E N/A 
Day Low $1.12    EPS $ 
Volume 154,077